Tổng hợp tài liệu :

ESC AF 2012 khotailieu y hoc

ESC pericardial disease 2004 khotailieu y hoc

ESC pericardial disease 2004 khotailieu y hoc
... constriction, typically without tissue calcification The symptoms may be masked by the underlying disease or the applied chemotherapy Imaging should start with echocardiography, followed by cardiac... insufficiency and ventricular wall rupture.80 Cardiac mortality and morbidity at pericardiectomy is mainly caused by the pre-surgically unrecognised presence of myocardial atrophy or myocardial... pericardiotomy (triamcinolone hexacetonide 50 mg every h for 2–3 days).140;147 Pericardiectomy is indicated only in refractory, severely symptomatic patients due to its potential morbidity and mortality
  • 24
  • 5
  • 0

ESC consensus antithrombotics AF statement 2014 khotailieu y hoc

ESC consensus antithrombotics AF statement 2014 khotailieu y hoc
... coronary syndrome; APT, antiplatelet therapy; CABG, coronary artery bypass graft surgery; CV, cardiovascular; ICH, intracranial haemorrhage; MI, myocardial infarction; NSTEMI, non-ST elevation myocardial... ACS, acute coronary syndrome; ACS-NSTEMI, acute coronary syndrome non-ST elevation myocardial infarction; ACS-STEMI, acute coronary syndrome ST elevation myocardial infarction; AF, atrial fibrillation;... registry Multi-centre Variables associated with AF Influence of AF on prognosis 30 days PCI registry AF vs non AF patients AF associated with in-hospital bleeds Lopes35 6925 Retrospective registry
  • 25
  • 5
  • 0

AHA AF 2014 summary khotailieu y hoc

AHA AF 2014 summary khotailieu y hoc
... Cardiovascular Risk in Asymptomatic Adults ACC /AHA 201010  Coronary Artery Bypass Graft Surgery ACC /AHA 201111  Hypertrophic Cardiomyopathy ACC /AHA 201112 ACC /AHA/ SCAI 201113 AHA/ ACC 201114... epidemiology, experimental, heart failure, hemodynamics, human, hyperthyroidism, hypothyroidism, meta-analysis, myocardial infarction, pharmacology, postoperative, pregnancy, pulmonary disease, quality... rhythm control, risks, sinus rhythm, symptoms, and tachycardia-mediated cardiomyopathy Additionally, the writing committee reviewed documents related to AF previously published by the ACC and AHA
  • 34
  • 8
  • 0

ESC EHRA AF novel AC NOAC 2015 khotailieu y hoc

ESC EHRA AF novel AC NOAC 2015 khotailieu y hoc
... patients with AF and coronary artery disease; (xiii) cardioversion in a NOAC- treated patient; (xiv) patients presenting with acute stroke while on NOACs; and (xv) NOACs vs VKAs in AF patients with... patients under NOAC therapy, nor is the best combination strategy known (in analogy for acute coronary syndome patients, described in ‘Patient with atrial fibrillation and coronary artery disease’... uniform and simple practical advice (e.g on the start of NOAC after cessation of VKA; on advice after a missed or forgotten dose) An EHRA website, www.NOACforAF.eu, accompanies the Practical Guide Whereas
  • 41
  • 8
  • 0

ESC dyslipidemia 2011 khotailieu y hoc

ESC dyslipidemia 2011 khotailieu y hoc
... failure Helsinki Heart Study human immunodeficiency virus hydroxymethylglutaryl coenzyme A homozygous familial hypercholesterolaemia Heart Protection Study Heart Protection Study Treatment of HDL to... through the CYP system but is metabolized by sulfation and conjugation CYP3A isoenzymes are the most abundant, but other isoenzymes such as CYP3A4, CYP2C8, CYP2C9, CYP2C19, and CYP2D6 are also... abdominal adiposity Physical activity should be encouraged, aiming at regular physical exercise for at least 30 min/day every day ESC/ EAS Guidelines ESC/ EAS Guidelines 1789 Table 11 Dietary recommendations
  • 50
  • 6
  • 0

ESC revascularization 2010 khotailieu y hoc

ESC revascularization 2010 khotailieu y hoc
... arrhythmia 7.4 Coronary angiography, percutaneous coronary intervention, and coronary artery bypass grafting An invasive strategy always starts with angiography After defining the anatomy and... Table 28 Graft patency after coronary artery bypass grafting (%) Graft Patency at year Patency at Patency at 4–5 years 10–15 years Ref SVG >90 65–80 25–50 47, 162 Radial artery 86–96 89 Not reported... for mechanical revascularization 8.1.4 Coronary artery bypass grafting Emergent coronary artery bypass grafting In cases of unfavourable anatomy for PCI or PCI failure, emergency CABG in evolving
  • 55
  • 9
  • 0

ESC PAD 2011 khotailieu y hoc

ESC PAD 2011 khotailieu y hoc
... Naftidrofuryl Naftidrofuryl has been available in Europe for many years It is a 5-hydroxytryptamine type antagonist that reduces erythrocyte and platelet aggregation The efficacy of naftidrofuryl was... Society for Vascular Surgery86 2009 1450 No No 95% 45% No No NA 5.7% NA NA EXACT87 2009 2145 Yes Yes Mandatory 10% Yes Yes 4.1% NA 7.0% 3.7% 2009 4175 Yes Yes Mandatory 13% Yes Yes 3.4% NA 6.2% 3.0%... >1000 patients Name Year N Industry sponsored Surgical high-risk EPD Sympt patients Neurologista CEC D/S D/S/MI D/S sympt D/S asympt CAPTURE83 2007 3500 Yes Yes Mandatory 14% Yes Yes 5.7% 6.3% 10.6%
  • 56
  • 10
  • 0

AHA NSTEMI UA 2012 khotailieu y hoc

AHA NSTEMI UA 2012 khotailieu y hoc
... ACCF, AHA, American Academy of Family Physicians, American College of Emergency Physicians, American College of Physicians, Society for Cardiovascular Angiography and Interventions, and Society of... Therapy Among initially stabilized patients with UA /NSTEMI for whom an early invasive strategy of coronary angiography is chosen, optimal timing of angiography has not been well defined Early or... http://circ.ahajournals.org/ by guest on March 24, 2013 Jneid et al Table 2012 UA /NSTEMI Focused Update 895 Recommendation for Quality Care and Outcomes for UA /NSTEMI 2012 Focused Update Recommendations 2012 Comments
  • 60
  • 4
  • 0

ESC dyslipidemia 2016 khotailieu y hoc

ESC dyslipidemia 2016 khotailieu y hoc
... body mass index coronary artery bypass graft surgery coronary artery calcium coronary artery disease Cholesterol and Recurrent Events cholesteryl ester transfer protein coronary heart disease carotid... respectively Physical inactivity Psychosocial stress including vital exhaustion Family history of premature CVD (men: <55 years; women: <60 years) Autoimmune and other inflammatory disorders Major psychiatric... NYHA PAD PCI PCSK9 PPAR-a PROCAM PROSPER PUFA RAAS RCT REACH REDUCE-IT heart failure Helsinki Heart Study human immunodeficiency virus hydroxymethylglutaryl-coenzyme A Heart Protection Study
  • 72
  • 10
  • 0

ESC hypertension 2013 khotailieu y hoc

ESC hypertension 2013 khotailieu y hoc
... Patients with Hypertension SYSTCHINA SYSTolic Hypertension in the Elderly: Chinese trial SYSTEUR SYSTolic Hypertension in Europe TIA transient ischaemic attack TOHP Trials Of Hypertension Prevention... twice by 42 European reviewers, half selected by ESH and half by ESC It can thus be confidently stated that the recommendations issued by the 2013 ESH /ESC guidelines on hypertension largely reflect... BP, such as younger age, male gender, smoking, alcohol consumption, physical activity, exercise-induced hypertension, anxiety, job stress, obesity, diabetes, CKD and family history of hypertension
  • 72
  • 5
  • 0

ESC prevention of CVD cardiovascular 2012 khotailieu y hoc

ESC prevention of CVD cardiovascular 2012 khotailieu y hoc
... loss of 85 million DALYs in 1990 to a loss of 150 million DALYs globally in 2020, thereby remaining the leading somatic cause of loss of productivity.1 1639 Joint ESC Guidelines CVD is strongly... mortality rates from CVD in the world 2.2 Prevention of cardiovascular disease: a lifelong approach Prevention of CVD ideally starts during pregnancy and lasts until the end of life In daily practice,... frequently feel nervous, anxious, or on edge? Anxiety Are you frequently unable to stop or control worrying? Do you frequently feel angry over little things? Hostility Do you often feel annoyed about
  • 77
  • 6
  • 0

ESC AF 2016 khotailieu y hoc

ESC AF 2016 khotailieu y hoc
... related to AFa 2b Moderate Normal daily activity not affected by symptoms related to AF, but patient troubled by symptomsa Severe Normal daily activity affected by symptoms related to AF Disabling... Rhythm Association symptom scale (modified from Wynn et al.199) Modified EHRA score Symptoms Description None AF does not cause any symptoms 2a Mild Normal daily activity not affected by symptoms... tachycardia is mainly found in patients after catheter ablation for AF, AF surgery, or after open heart surgery.158 Page 14 of 90 Table ESC Guidelines Clinical types of atrial fibrillationa AF type
  • 90
  • 19
  • 0

AHA ACC stable ischemic heart disease 2012 khotailieu y hoc

AHA ACC stable ischemic heart disease 2012 khotailieu y hoc
... al Stable Ischemic Heart Disease: Full Text JACC Vol 60, No 24, 2012 December 18, 2012: e44–e164 ACCF /AHA Task Force Members Jeffrey L Anderson, MD, FACC, FAHA, Chair Jonathan L Halperin, MD, FACC,... Hochman, MD, FACC, FAHA Sharon Ann Hunt, MD, FACC, FAHA§§ Richard J Kovacs, MD, FACC, FAHA Frederick G Kushner, MD, FACC, FAHA§§ Bruce W Lytle, MD, FACC, FAHA§§ Rick A Nishimura, MD, FACC, FAHA§§ E... Cardiovascular Risk in Asymptomatic Adults (5) ACCF /AHA 2010 Coronary Artery Bypass Graft Surgery (9) ACCF /AHA 2011 Percutaneous Coronary Intervention (10) ACCF /AHA/ SCAI 2011 Secondary Prevention and
  • 121
  • 11
  • 0

Aha AF 2014 khotailieu y hoc

Aha AF 2014 khotailieu y hoc
... epidemiology, experimental, heart failure, hemodynamics, human, hyperthyroidism, hypothyroidism, meta-analysis, myocardial infarction, pharmacology, postoperative, pregnancy, pulmonary disease, quality... Cardiovascular Risk in Asymptomatic Adults Coronary Artery Bypass Graft Surgery Hypertrophic Cardiomyopathy Percutaneous Coronary Intervention Secondary Prevention and Risk Reduction Therapy for Patients... rhythm control, risks, sinus rhythm, symptoms, and tachycardia-mediated cardiomyopathy Additionally, the committee reviewed documents related to atrial fibrillation (AF) previously published by
  • 175
  • 17
  • 0

ESC AF 2012 khotailieu y hoc

ESC AF 2012 khotailieu y hoc
... underlying pathophysiology is illustrated in Figure Key points † Rhythm-control therapy, whether by antiarrhythmic drugs or by catheter ablation, is indicated to relieve symptoms associated with AF. .. episodes of AF can be reduced or delayed by short-term (4 weeks post cardioversion) antiarrhythmic therapy may allow shorter treatment durations Antiarrhythmic drug therapy for AF has generally been... antiarrhythmic drug therapy should only be offered to control resistant symptoms due to recurrent AF and that a safety- 2736 ESC Guidelines Table Summary of clinical studies of dronedarone in AF Study
  • 29
  • 4
  • 0

ESC STEMI 2012 khotailieu y hoc

ESC STEMI 2012 khotailieu y hoc
... provision of timely reperfusion therapy to these patients If locally available, emergency coronary angiography is the modality of choice, as it can be followed immediately by primary PCI if the diagnosis... therapy 10 Patient delay System delay Time to reperfusion therapy Wire passage in culprit artery if primary PCI All delays are related to FMC (first medical contact) Figure Components of delay in STEMI. .. failure Efficacy and SUrvival Study ESC European Society of Cardiology ExTRACT-TIMI 25 Enoxaparin and Thrombolysis Reperfusion for ACute myocardial infarction Treatment— Thrombolysis In Myocardial
  • 52
  • 12
  • 0

AHA AF 2013 khotailieu y hoc

AHA AF 2013 khotailieu y hoc
... European Society of Cardiology; and in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society ACCF /AHA Task Force Members Jeffrey L Anderson, MD, FACC, FAHA, Chair;... Preexcitation Syndromes Class I Catheter ablation of the accessory pathway is recommended in symptomatic patients with AF who have Wolff-Parkinson-White Preexcitation syndrome, particularly those with syncope... procainamide may be considered to achieve pharmacological cardioversion in hemodynamically stable patients who develop AF during pregnancy (Level of Evidence: C) 1.4.6 Hypertrophic Cardiomyopathy Class
  • 12
  • 11
  • 0

AHA AF structural heart disease 2012 khotailieu y hoc

AHA AF structural heart disease 2012 khotailieu y hoc
... largely by symptoms Some patients, particularly those with structural heart disease, may tolerate AF poorly (ie, develop hemodynamic instability or pulmonary edema or experience rapid heart rates... appropriate Hypertrophic Cardiomyopathy Hypertrophic cardiomyopathy (HCM) is a genetic disorder characterized by unexplained LV hypertrophy and ventricular myocyte disarray.55,56 HCM is caused by a number... for rhythm control in structural heart disease NYHA indicates New York Heart Association; LVH, left ventricular hypertrophy; and LV, left ventricular Among those enrolled, 21% had a history of
  • 14
  • 3
  • 0

AHA antithrombotics in CKD 2012 khotailieu y hoc

AHA antithrombotics in CKD 2012 khotailieu y hoc
... Therapies Aspirin Aspirin selectively and irreversibly acetylates cyclooxygenase-1, thereby blocking the formation of thromboxane A2 in platelets.59 Aspirin is eliminated mainly by hepatic metabolism... unchanged in the urine to an extent that depends on the dosage and urinary pH Prostaglandininduced vasodilatation is important in maintaining renal blood flow in subjects with CKD. 60 By inhibiting... reduction in major cardiovascular events and mortality in hypertensive patients with CKD than in those with normal kidney function This finding can be explained in part by the high baseline risk of CKD
  • 14
  • 8
  • 0

ESC consensus antithrombotics AF 2009 khotailieu y hoc

ESC consensus antithrombotics AF 2009 khotailieu y hoc
... sudden death beyond 30 days of PCI) (51, 52) Most stent thromboses occur early (<30 days) or very late (>1 year) (49–51) The incidence of early stent thrombosis (<30 days) is considerably increased... 75 years (Age 65 to 74 y) Advanced age (>75 years) Heart failure or moderate-severe left ventricular dysfunction on echocardiography [eg Ejection fraction =40%] (Vascular disease) History of myocardial... Pharmacokinetic-pharmacodynamic considerations and evidence for „rebound“ hypercoagulability after stopping anticoagulants Clin Pharmacokinet 1996; 30: 300–313 79 White H, Kleiman N, Mahaffey K, et al Efficacy and safety
  • 15
  • 14
  • 0
1 2 3 4 .. >